Rainer Hohl
Nuernberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Underexposure of linezolid in critically ill patients with extracorporeal membrane oxygenation (ECMO): results from a monocentric study including blood samples from 52 patients.
Journal: Infection
Published: September 12, 2025
Correction to: High rates of Cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.
Journal: Critical care (London, England)
Published: August 22, 2025
High rates of cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.
Journal: Critical care (London, England)
Published: October 18, 2024
Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.
Journal: ACS pharmacology & translational science
Published: May 13, 2020
Calculated initial parenteral treatment of bacterial infections: Sepsis.
Journal: GMS infectious diseases
Published: May 07, 2020
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro.
Journal: European journal of clinical pharmacology
Published: April 25, 2020
Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients.
Journal: Clinical laboratory
Published: September 19, 2019
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics.
Journal: Pharmaceutics
Published: May 17, 2019
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding.
Journal: Pharmaceutics
Published: March 31, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026